1Department of Medicine II, University of Freiburg, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Chronic hepatitis C (HCV) treatments are evolving. Novel antiviral therapies targeting viral replication and enhancing immune responses show promise for managing liver cirrhosis and cancer.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: